IDSA Media Briefing: COVID-19 Vaccine Development

A media briefing with experts from the Infectious Diseases Society of America to discuss coronavirus and COVID-19 developments and answer questions.

Topical Agenda for February 18 briefing:

• Vaccine development and approval processes for COVID-19 compared to previous vaccines
• Evidence and safety data available
• Ongoing studies of special populations and monitoring
• Questions from media

FEATURING:

• Dial Hewlett Jr., MD, FIDSA—White Plains, NY
  Fellow—Infectious Diseases Society of America
  Medical Director, Division of Disease Control, Westchester County Department of Health
  Member, National Medical Association COVID-19 Task Force on Vaccines and Therapeutics
• Matthew Zahn, MD, FIDSA—Santa Ana, CA
  Fellow—Infectious Diseases Society of America
  Medical Director, Division of Epidemiology and Assessment, Orange County Health Care Agency
  Liaison Representative, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention
• Amanda Jezek (Moderator)
  Senior Vice President, Public Policy & Government Relations—Infectious Diseases Society of America